While the prognosis for elderly patients with primary central nervous system lymphoma (PCNSL) is poor, results from a Dutch, nationwide population-based study show survival benefits associated with primary therapy, especially chemotherapy (CT).
While the prognosis for elderly patients with primary central nervous system lymphoma (PCNSL) is poor, results from a Dutch, nationwide population-based study show survival benefits associated with primary therapy, especially chemotherapy (CT).